Does percutaneous coronary intervention with drug-eluting stents compared to coronary bypass surgery improve clinical outcomes in patients with coronary artery disease?
At 5 years, CABG offers a clinically relevant benefit over DES-PCI for mortality, MI, and repeat revascularization in patients with coronary artery disease, though it carries a higher risk of stroke.
The current data suggest a clinically relevant benefit of CABG over DES-PCI at 5 years in terms of mortality, myocardial infarction, and repeat revascularization, despite an increased risk of stroke. These findings may guide the heart-team and the shared decision-making process.
Kawczyński et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: